Showing results (61-70 of 2,881) with videos related to
Sort By:
Pageof 289
International Journal of Cardiology|July 14, 2016
Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trialKeitaro Senoo, Gregory Y H LipThe Cochrane Database of Systematic Reviews|April 1, 2014
Anticoagulation versus placebo for heart failure in sinus rhythmGregory Y H Lip, Eduard ShantsilaSeminars in Thrombosis and Hemostasis|January 28, 2017
Risk Stratification Models in Atrial FibrillationFarhan Shahid, Gregory Y H LipProgress in Cardiovascular Diseases|October 4, 2015
Preventing Thrombosis to Improve Outcomes in Heart Failure PatientsEduard Shantsila, Gregory Y H LipPolskie Archiwum Medycyny Wewnetrznej|February 23, 2012
A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?Nicoletta Riva, Gregory Y H LipVascular Health and Risk Management|March 26, 2016
Edoxaban in venous thromboembolism and stroke prevention: an appraisalMarco Proietti, Gregory Y H LipThe American Journal of Medicine|April 19, 2016
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range Observations from the SPORTIF TrialsMarco Proietti, Gregory Y H LipBMC Medicine|January 11, 2005
Blood pressure demographics: nature or nurture ... ... genes or environment?Joseph Tomson, Gregory Y H LipExpert Opinion on Investigational Drugs|May 25, 2004
Platelet activation in the hypertensive disorders of pregnancySunil Nadar, Gregory Y H LipContributions to Nephrology|May 9, 2013
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulationYousif Ahmad, Gregory Y H LipPageof 289